文献速递免疫规划慢病防控与筛查

使用回归断点设计评估英格兰人乳头瘤病毒疫苗接种规划的效果

Evaluating the effectiveness of the human papillomavirus vaccination programme in England, using a regression discontinuity design.
PubMed 文献 · Int J Epidemiol · 2025-01-01

英格兰2008年引入国家人乳头瘤病毒(HPV)免疫规划,对12-13岁女孩常规接种,并对14-18岁女孩补种。利用2011年人口普查、医院 Episode Statistics 和死亡数据,采用回归断点设计评估补种规划对宫颈癌及宫颈异型增生的影响,显示23-30岁女性中宫颈异型增生和癌症诊断分别减少31%和75%,常规接种者中减少持续存在。

要点

  • 在17-18岁获补种疫苗的女孩中,23-30岁时宫颈异型增生诊断减少31%,宫颈癌诊断减少75%。
  • 与刚好超过补种疫苗资格年龄者相比,补种疫苗接种者宫颈疾病诊断出现明显断点。
  • 常规接种疫苗的女孩中,宫颈疾病诊断的减少持续存在。

核心结论

  • 采用准实验方法获得的疫苗效果估计与基于更传统方法的效果估计相似。
  • 该研究进一步提供证据表明HPV疫苗接种规划减少年轻女性不良宫颈结局,该方法可用于未来评估HPV疫苗接种政策的重大变化以及包括其他癌症和死亡在内的长期结局研究。

研究设计与样本

  • 利用2011年人口普查、医院 Episode Statistics 和英格兰人口死亡数据,利用资格截止点应用回归断点设计评估HPV疫苗接种对宫颈疾病的影响。

主要发现

  • 在17-18岁获补种疫苗的女孩中,与刚好超过补种疫苗资格年龄者相比,23-30岁时宫颈异型增生诊断减少31%,宫颈癌诊断减少75%,并出现明显断点。
  • 在常规接种疫苗的女孩中,减少持续存在。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In England, the national human papillomavirus (HPV) immunization programme was introduced in 2008 to prevent cervical cancer. Girls aged 12-13 years were offered routine vaccination and those aged 14-18 years in 2008 were offered 'catch-up' vaccination. We evaluate the effect of the HPV catch-up vaccination programmes on cervical cancer and cervical dysplasia diagnoses, and provide an estimate of the vaccine effectiveness. METHODS: Using the 2011 Census, Hospital Episode Statistics, and mortality data for the population of England, we exploit the cut-off in eligibility and apply a regression discontinuity design to assess the impact of HPV vaccination on cervical disease. RESULTS: Vaccination reduced the incidence of cervical dysplasia and cancer diagnoses by 31% and 75%, respectively, at ages 23-30 years in girls offered catch-up vaccination at ages 17-18 years compared with those who were just above the eligibility age for the catch-up vaccination, with a clear discontinuity. Reductions continued amongst girls offered routine vaccination. CONCLUSION: These estimates, obtained by using a quasi-experimental approach, are similar to vaccine effectiveness estimates based on more traditional approaches. This approach provides further evidence of the HPV vaccination programme reducing adverse cervical outcomes in young women and could be used for future studies to evaluate major changes in HPV vaccination policy and for studies of longer-term outcomes including other cancers and deaths.

来源:Int J Epidemiol,查看原文。版权归原作者所有。

引用

  1. Ward IL, Bermingham CR, Soldan K, et al. Evaluating the effectiveness of the human papillomavirus vaccination programme in England, using a regression discontinuity design. Int J Epidemiol. 2025. PMID: 40990251. doi:10.1093/ije/dyaf156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。